
è«æâç®èç§ãä»ãæ¥çš®ããŠãã人ã«å±ããŸãããã«ã
2021幎ãã¯ã¯ãã³ã®å€§èŠæš¡æ¥çš®ãå§ãŸã£ãé ã¯ãä»ãŸã§ã®ç§åŠçãªç¥èŠããäºæž¬ããããªã¹ã¯ãç ç©¶è ãå»åž«ã®æ¹ã ãäŒããŠãããŠããŸããã
ã§ããä»ã¯ãã®é ãšã¯éããŸãããã§ã«è«æããŒã¹ã§ãªã¯ã¹ãã¯ã£ããããŠããŸãã
2023幎11æçŸåšãä»ãæ¥çš®ãç¶ããŠãã人ã«å±ããŸãããã«ã
ð é«ç¥å€§åŠããã®è«æãäºã€ã§ãð
ðäžã€ç®ð
å
¬éæ¥:2022幎8æ25æ¥
ïŒèªå翻蚳ïŒãmRNA COVID-19 ã¯ã¯ãã³æ¥çš®åŸã®æç¶çãªæ°Žç垯ç¶ç±ç¹ãŠã€ã«ã¹ææã¯ãç
å€å
ã®ã³ãŒããããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®ååšãšé¢é£ããŠããã
https://onlinelibrary.wiley.com/doi/10.1002/cia2.12278
äžèšã®è«æã玹ä»ããŠããé«ç¥å€§åŠã®ããŒãžã¯ãã¡ãð
ãäœéæ çŽç¹ä»»ææãã®ç ç©¶ããŒã ã®è«æããJournal of Cutaneous Immunology and Allergyãã«æ²èŒãããŸããïŒ2022幎9æ9æ¥ïŒã
äžèšã®ããŒãžããåŒçš
ãæ¬éŠã§ã¯ãåœæ°ã®ïŒå²ä»¥äžã2021幎ããéå§ãããæ°åã³ãããŠã€ã«ã¹(COVID-19)ã®mRNAã¯ã¯ãã³ã®ïŒåç®æ¥çš®ãå®äºããŠããŸãããç®èé害ãå«ãæ§ã ãªå¯äœçšã倿°å ±åãããŠããŸãã
ãäœéæ çŽç¹ä»»ææãã¯ãã¯ã¯ãã³æ¥çš®åŸã«ç®èçç¶ãçºçŸããæ£è ã®ç®ç¹éšã調ã¹ãçµæãCOVID-19ã®ã¹ãã€ã¯èçœïŒâ»ïŒãæ€åºãããããšãããã¯ã¯ãã³ã®å¯äœçšãšããŠmRNAãã³ãŒãããã¹ãã€ã¯èçœãç®èç æ ã«é¢äžããŠããå¯èœæ§ã瀺åããŸããã
ãæ¬ç ç©¶ã¯ç®èã§ã®æ€èšã§ããããä»åŸèåšã§çºçŸããã¹ãã€ã¯ã«ãããŠãåæ§ã«èšŒæããããšãã§ããã°ãmRNAã¯ã¯ãã³ã«ããèåšå¥å¯äœçšã®èšŒæ ãšãªããããããããŸããã
ãã®è«æã詳ãã説æããŠãããŠããnoteã¯ãã¡ãã§ãð
2022幎9æ10æ¥ããã€ãã³å
ç
ããã¡ã€ã¶ãŒã®ã³ããã¯ã¯ãã³å¯åå¿ã®åž¯ç¶ç±ç¹ã§Sèçœãæ€åºãããã
ðäºã€ç®ð
å
¬éæ¥:2023幎5æ8æ¥
ïŒèªå翻蚳ïŒãæ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒmRNAã¯ã¯ãã³æ¥çš®åŸã®æç¶çé坿§é»æäžç¹æ§çŽ
æã®çäŸã¯ãçç®æ·±éšã®è¡ç®¡å
ç®çްèãšãšã¯ãªã³è
ºã«ãã£ãŠçºçŸãããç
å€å
ã¹ãã€ã¯ã¿ã³ãã¯è³ªãšé¢é£ããŠããå¯èœæ§ãããã
https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.16816
äžèšè«æã®äžéšïŒèªå翻蚳ã«ããïŒð
ä»åæã ã¯ãæ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒã¡ãã»ã³ãžã£ãŒRNAïŒmRNAïŒã¯ã¯ãã³ïŒBNT162b2ïŒã®2åç®ã®æäžåŸã«çºçãããé坿§æç¶äžç¹æ§çŽ æãåãã86æ³ã®æ¥æ¬äººå¥³æ§ãå ±åããã圌女ã®ç®èç å€ã¯æéã®çµéãšãšãã«åºããã3 ãæä»¥äžç¶ããŸãããé©ãã¹ãããšã«ãçºçãã100æ¥åŸã®ç å€ã®å ç«çµç¹ååŠçæè²ã«ãããçç®æ·±éšã®è¡ç®¡å ç®çްèãšãšã¯ãªã³è ºã«ãã£ãŠçºçŸãããæ°åã³ãããŠã€ã«ã¹ææçã¹ãã€ã¯ã¿ã³ãã¯è³ªãæããã«ãªã£ãã圌女ã«ã¯æ°åã³ãããŠã€ã«ã¹ææçã®ãšããœãŒãããªãã£ããããã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯mRNAã¯ã¯ãã³ã«ç±æ¥ããå¯èœæ§ãé«ããããã圌女ã®ç®èç å€ã®çºçãšæç¶ã®åå ã§ããå¯èœæ§ããããŸãã圌女ã®çç¶ã¯é·æã«ãããããã¬ãããŸãã³ã®çµå£æäžãè¡ããããŸã§é£æ²»æ§ã§ããã
ãã®è«æã詳ãã説æããŠãããŠããnoteã¯ãã¡ãã§ãð
2023幎5æ22æ¥ããã€ãã³å
ç
ãæ°ããé«ç¥å»å€§ã»äœéå
çãã¡ããã®mRNAã¯ã¯ãã³æ¥çš®åŸç®èçã®ã玹ä»ã§ãã
ð ð ð ð ð ð ð ð ð ð ð ð ð ð ð ð
äºã€ã®è«æã®å·çè ã®äžäººã§ããé«ç¥å€§åŠå»åŠéšã®äœéæ çŽç¹ä»»ææãåºæŒãããŠãããã¬ãçªçµã¯ãã¡ãðã§ããäžã€ç®ã®è«æã«ã€ããŠã®èª¬æããããŸãã
2023幎1æ6æ¥ãCBCãã¥ãŒã¹
æ¥çš®åŸã®æ»äº¡ãå¯åå¿ã¯ãªãïŒæ°åã³ããã¯ã¯ãã³ã®å
ãšåœ± åœã®ææžå¶åºŠã®è¡æ¹ã¯âŠãå ±éã®ãã«ã©ã
äœéæ çŽç¹ä»»ææãç»å Žããã®ã¯ã7:45ïœã§ãã
åç»è§£èª¬æããã®äžéšæç²ã§ãð
ã¯ã¯ãã³æ¥çš®åŸã®ç®èçŸæ£ç ç©¶ã§èŠã€ãã£ãã®ã¯âŠ
ããããäžãå¯åå¿ã®ä»çµã¿ã調ã¹ãå»åž«ãâŠ
é«ç¥å€§åŠå»åŠéšã
ã¯ã¯ãã³æ¥çš®åŸã«èµ·ããç®èã®çŸæ£ãç ç©¶ããŠããäœéæ çŽç¹ä»»ææã
åçã¯70代ã®ç·æ§æ£è ã§ãå³è äžè éšã®ç®èã®çµç¹ã壿»ãèµ·ãããŠããŸãã
ä»ã«ã垯ç¶ç±ç¹ãäžæŠæ²»ã£ãŠãããã«ãã¹ã®åçºãªã©ãã¯ã¯ãã³æ¥çš®åŸã«ç®èçŸæ£ãèµ·ããæ£è ãäœäººã蚺å¯ããäœéç¹ä»»ææã¯ãæ£éšã®çµç¹ãç¹æ®ãªææã§æããæ¹æ³ã§èª¿ã¹ãŸããã
ããã«èŠã€ãã£ãã®ã¯âŠ
ãã°ãªãŒã³ã«æãŸã£ãŠãããšãããâã¹ãã€ã¯ã¿ã³ãã¯âãªãã§ããã¯ã¯ãã³ç±æ¥ã®âã¹ãã€ã¯ã¿ã³ãã¯âãç®èã§èŠã€ãã£ãã
ç®èã®ççéšåã§èŠã€ãã£ãã®ã¯ãã¯ã¯ãã³ãäœãåºããâã¹ãã€ã¯ã¿ã³ãã¯âãšããç©è³ªã
ã¹ãã€ã¯ã¿ã³ãã¯ã¯ãŠã€ã«ã¹ã®è¡šé¢ã«ããâãã²âã®ãããªãã®ã
人ã®å ç«ã¯ãã®ãã²ã®åœ¢ãèŠããããšã§ãŠã€ã«ã¹ãæ»æã§ããããã«ãªããŸãã
ãã¡ã€ã¶ãŒç€Ÿãã¢ãã«ã瀟ã®ã¯ã¯ãã³ã¯ãŠã€ã«ã¹ã®éºäŒåããŒã¿ã®äžéšãæ³šå ¥ããããã®çްèã«ã¹ãã€ã¯ã¿ã³ãã¯ãäœãããããšã§å ç«ãçã¿åºãä»çµã¿ã§ãã
ãã®ã¹ãã€ã¯ã¿ã³ãã¯ãççéšåã«éãŸã£ãŠããããšã¯äœãæå³ããã®ãâŠ
ïŒé«ç¥å€§åŠå»åŠéš äœéæ çŽç¹ä»»ææïŒ
ãã¹ãã€ã¯ã¿ã³ãã¯ããã©ãã©ãã£ãŠãããã§å±æã§å ç«ãäžããŠããããã«ããã«ãã¹ãŠã€ã«ã¹ã®å掻æ§åãä¿ããŠããã
äœéç¹ä»»ææã¯ã¯ã¯ãã³æ¥çš®ã«ãã£ãŠäœå ã§äœãããã¹ãã€ã¯ã¿ã³ãã¯ãã®ãã®ãå ç«åãäœäžãããç®èçŸæ£ãªã©æ§ã ãªå¯åå¿ãåŒãèµ·ãããŠããå¯èœæ§ãææããŸãã
ïŒé«ç¥å€§åŠå»åŠéš äœéæ çŽç¹ä»»ææïŒ
ãå¯äœçšãšããŠã®ã¹ãã€ã¯ã¿ã³ãã¯ã®åãã¯è¡æ ãäœãã屿ã®ççãèªçºãããšããããšããããŸãã
ïŒå ç«åäžãããªãææçã«ãªãããããªãã®ã§ã¯ïŒ
ïŒé«ç¥å€§åŠå»åŠéš äœéæ çŽç¹ä»»ææïŒ
ãã¯ã¯ãã³ãæã£ãŠãäººã®æ¹ãéã«ã³ããã«ããããããã
ð ð ð ð ð ð ð ð ð ð ð ð ð ð ð ð ð ð ð ð
以äžã¯ãèªåçšã®ã¡ã¢ã§ãã
äžèšäºã€ã®ç®èç§ã®è«æãšã¯å¥ã®çäŸã«é¢ããã話ãã§ãã
ã§ããç¹ããäºãæžããŠãããããªæ°ãããã
é£ããããã©ã倧äºãªäºãæžãããŠãããšæãã®ã§ãã³ã³ã«ã眮ããŠãããããããã«æ¢ããŠèªã¿çŽããããã«ã
äžèšnoteããäžéšæç²ããŸãã
ãªãå šãŠã®ãã现èã«ã¹ãã€ã¯èçœè³ªãååšããã®ã§ãããïŒ
次㮠1) ãš 2)ã®ã©ã¡ãã確ãããããšèããŸããïŒ
1) æ¢ã«ã§ããŠããæªæ§ãªã³ãè «ã®æªæ§çްèã®1ã€ïŒã€ã«ã¯ã¯ãã³ã®ã¹ãã€ã¯èçœè³ªãã³ãŒããã modRNA ãå ¥ã£ããããããåã ã®çްèã§ã¹ãã€ã¯èçœè³ªãçåæãããã
2) 1ã€ã®çްèã®éºäŒåã«ã¹ãã€ã¯èçœè³ªãã³ãŒãããéºäŒåãçµã¿èŸŒãŸãããã¹ãã€ã¯èçœè³ªã®éºäŒåãçµã¿èŸŒãŸãã现èãåªå çã«å¢æ®ããŠããã